XML 29 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
Net Loss Per Common Share (Details)
1 Months Ended 3 Months Ended
Jan. 30, 2013
Mar. 31, 2013
Mar. 31, 2012
Net Loss Per Common Share [Abstract]      
Number of Series B Preferred shares converted (in shares) (7,866,800)    
Number of shares issued upon conversion of Series B Preferred shares (in shares)   1,048,907  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (in shares)   6,165,733 4,318,786
Shares Authorized for Issuance [Line Items]      
Common stock for possible for future issuance (in shares)   9,738,968  
Exercise of Stock Warrants [Member]
     
Shares Authorized for Issuance [Line Items]      
Common stock for possible for future issuance (in shares)   1,367,063  
Exercise of Stock Purchase Right [Member]
     
Shares Authorized for Issuance [Line Items]      
Common stock for possible for future issuance (in shares)   4,051,986  
Exercise of Preferred Stock [Member]
     
Shares Authorized for Issuance [Line Items]      
Common stock for possible for future issuance (in shares)   1,333,333  
Issuance of Restricted Stock Grants [Member]
     
Shares Authorized for Issuance [Line Items]      
Common stock for possible for future issuance (in shares)   28,965  
Contingent Issuable Shares in Connection with Entity Acquisition [Member]
     
Shares Authorized for Issuance [Line Items]      
Common stock for possible for future issuance (in shares)   490,548  
Issuable shares from conversion of promissory note payable [Member]
     
Shares Authorized for Issuance [Line Items]      
Common stock for possible for future issuance (in shares)   2,030,835  
Additional common stock due to reset provision [Member]
     
Shares Authorized for Issuance [Line Items]      
Common stock for possible for future issuance (in shares)   436,238  
Warrants [Member]
     
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (in shares)   1,367,063 361,912
Stock Purchase Right [Member]
     
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (in shares)   0 75,000
Options [Member]
     
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (in shares)   1,584,501 1,579,634
Series A Preferred Stock [Member]
     
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (in shares)   933,333 933,333
Series B Preferred Stock [Member]
     
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (in shares)   0 1,368,907
Series C Preferred Stock [Member]
     
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (in shares)   250,000 0
Convertible promissory note [Member]
     
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (in shares)   2,030,835 0